A detailed history of Engineers Gate Manager LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 27,408 shares of VKTX stock, worth $1.41 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
27,408
Previous 9,733 181.6%
Holding current value
$1.41 Million
Previous $515,000 236.89%
% of portfolio
0.04%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$49.84 - $70.47 $880,922 - $1.25 Million
17,675 Added 181.6%
27,408 $1.74 Million
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $461,246 - $780,586
9,733 New
9,733 $515,000
Q4 2023

Feb 14, 2024

SELL
$9.24 - $19.64 $385,677 - $819,773
-41,740 Reduced 75.08%
13,853 $257,000
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $607,075 - $889,488
55,593 New
55,593 $615,000
Q1 2023

May 15, 2023

BUY
$8.08 - $17.33 $113,394 - $243,209
14,034 New
14,034 $233,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $3.15 $26,100 - $38,965
-12,370 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.0 - $4.88 $37,110 - $60,365
12,370 New
12,370 $37,000
Q2 2020

Aug 17, 2020

SELL
$4.35 - $8.08 $45,674 - $84,840
-10,500 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$3.45 - $7.95 $36,225 - $83,475
10,500 New
10,500 $49,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.95B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.